STATIN MEDICATIONS

Course overview

STATIN MEDICATIONS ARE USED IN THE MANAGEMENT AND TREATMENT OF HYPERCHOLESTEREMIA. THEY ARE KNOWN TO BE INHIBITORS OF THE HYDROXYMETHYLGLUTARYL-COA REDUCTASE ENZYME AND LOWER TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL), AND TRIGLYCERIDE CONCENTRATIONS WHILE INCREASING HIGH-DENSITY LIPOPROTEIN (HDL) CONCENTRATIONS. FDA-APPROVED STATINS INCLUDE ATORVASTATIN, ROSUVASTATIN, SIMVASTATIN, PRAVASTATIN, FLUVASTATIN, LOVASTATIN, AND PITAVASTATIN.THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTIONS, AND CONTRAINDICATIONS FOR STATINS AS A VALUABLE AGENT IN TREATING HYPERCHOLESTEREMIA. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, DOSING, AND MONITORING PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH HYPOCHOLESTEREMIA.